Abivax ADR (NASDAQ: ABVX) is -19.13% lower on its value in year-to-date trading and has touched a low of $5.49 and a high of $17.02 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABVX stock was last observed hovering at around $6.30 in the last trading session, with the day’s loss setting it -0.38%.
Currently trading at $5.92, the stock is -19.26% and -12.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.19 million and changing -6.03% at the moment leaves the stock -41.01% off its SMA200. ABVX registered -55.35% loss for a year compared to 6-month loss of -49.66%. The firm has a 50-day simple moving average (SMA 50) of $6.78226 and a 200-day simple moving average (SMA200) of $10.03519.
The stock witnessed a -10.27% gain in the last 1 month and extending the period to 3 months gives it a -30.35%, and is -28.59% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.64% over the week and 7.21% over the month.
Abivax ADR (ABVX) has around 61 employees, a market worth around $375.15M and $0.00M in sales. Distance from 52-week low is 7.73% and -65.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-95.44%).
The EPS is expected to grow by 22.89% this year
51.0 institutions hold shares in Abivax ADR (ABVX), with institutional investors hold 47.53% of the company’s shares. The shares outstanding are 62.92M, and float is at 55.12M with Short Float at 2.24%. Institutions hold 47.53% of the Float.
